The current institutional shareholding score of Ovid Therapeutics Inc is 3.00, ranking 192 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 39.21%, representing a quarter-over-quarter increase of 16.68%. The largest institutional shareholder is Steven Cohen, holding a total of 1.15M shares, representing 0.87% of shares outstanding, with 22.95% increase in holdings.
Institutional Shareholding
Shareholder Activity
Name
Shares Held
Chg %
RA Capital Management, LP
10.71M
--
Takeda Pharmaceutical Co Ltd
8.78M
+16.60%
Affinity Asset Advisors LLC
7.15M
--
Adar1 Capital Management LLC
4.29M
+33256.69%
Eventide Asset Management, LLC
4.29M
--
Levin (Jeremy M)
3.77M
+1.27%
Federated Hermes Global Investment Management Corp.